perfluorooctane-sulfonic-acid-CAS-1763-23-1-—-Safety-Data-Sheet CAS_NUMBER 1763-23-1 (zh_CN)

perfluorooctane sulfonic acid (CAS 1763-23-1) — Safety Data Sheet

EU · REACH Annex XIVMolGod评分：主要

Safety data sheet documentation for perfluorooctane sulfonic acid (CAS 1763-23-1), compiled to REACH Annex II with classification read against the harmonised entry in CLP Annex VI (H351, H360D, H362, H332). Two options: a working draft sent by e-mail immediately, or a signed card issued within 72 hours of complete input. The item supplied is a document — MolGod.org does not sell, supply or ship chemical substances.

Free, and generated automatically from the sources listed on this page. No person has reviewed it, and it describes the substance in general — not your material, your process or your intended market.

REACH 2020/878
v4 · 07.09.2026
下载安全数据表 (PDF)CAS 1763-23-1 · PDF · 178 KB工作草稿 — 尚未经过审核和批准。

第 9 部分 — 理化特性：已确定 5 项，共 22 项。

我们展示已确定的内容，并指明尚未确定的内容。每张卡片上的分类和标识信息都是完整的；公开数据较少的是第9部分。

本页出售的是该物质的文件，而非物质本身。请选择您所需的级别。

  1. €0审核您现有的文件将您现有的该物质文件发给我们，我们会告诉您其中有哪些问题。每家公司限一次。如果文件没有问题，您无需购买任何东西。开始免费审核 →
  2. €49.99工作草案完整的十六部分文件，附参考文献，结账后可立即下载。在文书工作尚未定稿时的合适选择。
  3. €249.99签署版文件同一份文件经审核并签署，在收到完整资料后 72 小时内出具 — 以备官方询问由谁对其负责之时。

该物质可提供的文件： 安全数据表 · CLP 标签 · 分析证书（应要求提供） · 规格书。语言：您目标市场的官方语言，按每份文件单独制作。

此处不显示等级、纯度、物理形态、包装、最小起订量和交货期，因为 MolGod 不供应该物料 — 这些是关于卖方的信息，而本页没有卖方。它们会出现在我们为供应商搭建的店铺中，在那里有人能对其负责。

先查看成品文件完整价目表 →

您将收到的内容 — 以及这不是什么

您将收到的内容

  • 一份数字 PDF 安全数据表，采用 REACH 附件 II（法规 1907/2006）规定的十六部分结构。
  • 物质标识、危害分类、理化、毒理学和生态学信息以及法规参考。
  • 如该物质在 CLP 附件 VI 中有统一分类条目，则依据该条目核对分类。
  • 版本号、编制日期，以及每个附有来源的数值所依据的来源。
  • 通过电子邮件交付，不寄送任何实物。

这不是什么

  • 不是化学物质，不是样品，也不是任何实物商品。
  • 这不是认证。欧盟不存在针对安全数据表的官方认证制度。
  • 不构成法律批准，也不保证在任何司法管辖区合规。
  • 不能替代您自己的法规评估，也不能替代您实际持有物质的制造商或进口商提供的安全数据表。
  • 除非您提供相关信息，否则不针对特定工作场所、工艺或国家附录进行调整。

当现有证据不足以支持某一数值时，数据表会注明该数值未确定，而不是进行估算。没有记录来源的字段会被如实标注。

买方资料包包含哪些内容

您的合规专员会要求的一切，集中在一个文件中。

  • PDF 格式的产品页面 — 与发布内容一致的记录，确保您转发的内容与您阅读的内容相符。
  • 与您权限级别相应的安全数据表 — 按 REACH 附件 II 规定顺序排列的十六个部分，针对该物质，采用您选择的语言。
  • CLP 标签设计稿 — 与安全数据表基于同一分类生成，因此两者不可能互相矛盾。
  • 规格书，以及在有批次数据时提供的分析证书。
  • sources.txt — 每条引用均注明查阅日期。
  • 我们无法确定事项的明确清单 — 相关字段标注为“不可用”，而不是用估计值填充。这是文件中诚实的部分，我们不会把它藏在脚注里。

您的欧洲买方会把这些资料转发给没有参加通话的人。资料包的意义在于，让其转发的内容完整、不言自明且可追溯 — 而不是四个附件加一句以 “我想就这些了” 开头的话。

SKU: SDS-1763-23-1 Category: Tags: , , , , , , , , , , , , ,

这些选项用于切换本页面的语言。 Single substances. Mixtures on enquiry. One document, one language — additional languages are priced separately. Every version, including the Chinese one, is written to EU law — (EC) No 1907/2006 (REACH) Annex II and (EU) 2020/878 — and translated from it. The Chinese version is a reference translation, not a legally valid document for the Chinese market: an SDS for China must be compiled separately to GB/T 16483 and GB/T 17519.

🧬 3D分子可视化器
正在加载分子...
3D模型Perfluorooctanesulfonic acid，CAS 1763-23-1，分子式C8HF17O3S, 摩尔质量 500.13 g/mol

数据转录自法规登记册和专业文献，并注明来源与版本。不能替代供应商的安全数据表。未记录来源的字段已作相应标注。

📊 物理化学数据 — CAS 1763-23-1
📊 物理化学性质

快速参考

化学式： C8HF17O3S
分子量： 500.13 g/mol
CAS号： 1763-23-1
外观： 液体
🔬 高级属性

化学标识符

SMILES: C(C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F

最后更新： 2026-08-25

化学概述: Perfluorooctanesulfonic acid
分子式C8HF17O3S[1]
分子量500.13 g/mol[1]
LogP（亲脂性）5[1]
IUPAC名称1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid[1]
SMILESC(C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F[1]
InChIKeyYFSUTJLHUFNCNZ-UHFFFAOYSA-N[1]

同义词: Perfluorooctanesulfonic acid · 1763-23-1 · PFOS · Perfluorooctane sulfonic acid · Perfluorooctylsulfonic acid

数据来源： PubChem (NLM/NIH)
最后更新： 2026-08-25

📚 科学参考文献（芝加哥作者-日期格式） (1 来源)
  1. PubChem. National Center for Biotechnology Information (NIH/NLM), chemical compound database. ↗ applies to: 分子式 · 分子量 · LogP（亲脂性） · IUPAC名称 · SMILES · InChIKey

科学研究

[1]CrossRef2026
Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"
(2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review1
查看完整研究 ↗
[2]CrossRef2026
Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"
(2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review2
查看完整研究 ↗
[3]CrossRef2026
Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"
(2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review1
查看完整研究 ↗
[4]CrossRef2026
Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"
(2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review2
查看完整研究 ↗
[5]PubMed2026
Elucidating the molecular mechanisms of perfluorodecanoic acid and perfluorooctane sulfonic acid on glioblastoma through network toxicology and bioinformatics.
Chen T, Liang H, Huang Q et al.. (2026). "Elucidating the molecular mechanisms of perfluorodecanoic acid and perfluorooctane sulfonic acid on glioblastoma through network toxicology and bioinformatics
查看完整研究 ↗
[6]PubMed2026
Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis.
Yu J, Huang S, Zhang J et al.. (2026). "Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis.". Journal of hazardous materials. ht
查看完整研究 ↗
[7]PubMed2025
Perfluorooctanoic acid and perfluorooctanesulfonic acid induce resistance to chemotherapy in colorectal cancer.
Liu J, Pang X, Li X et al.. (2025). "Perfluorooctanoic acid and perfluorooctanesulfonic acid induce resistance to chemotherapy in colorectal cancer.". Journal of hazardous materials. https://doi.org/1
查看完整研究 ↗
[8]PubMed2025
Associations of PFOA and PFOS exposure with liver injury: Evidence from Two Population Studies and integrative adverse outcome…
You Y, Guan X, Zhao H et al.. (2025). "Associations of PFOA and PFOS exposure with liver injury: Evidence from Two Population Studies and integrative adverse outcome pathway analysis.". Environmental
查看完整研究 ↗
📚 科学参考文献（芝加哥作者-日期格式） 13 refs · 2 baz

MOLECULE 按CAS号参考文献（实时来自13+数据库）

来源： db:crossref (7) · db:pubmed (7)

  1. db:crossref (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review1 →
  2. db:crossref (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review2 →
  3. db:crossref (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review1 →
  4. db:crossref (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review2 →
  5. db:pubmed Yu J, Huang S, Zhang J et al.. (2026). "Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis.". Journal of hazardous materials. https://doi.org/10.1016/j.jhazmat.2025.140750 →
  6. db:pubmed Liu J, Pang X, Li X et al.. (2025). "Perfluorooctanoic acid and perfluorooctanesulfonic acid induce resistance to chemotherapy in colorectal cancer.". Journal of hazardous materials. https://doi.org/10.1016/j.jhazmat.2025.140583 →
  7. db:pubmed You Y, Guan X, Zhao H et al.. (2025). "Associations of PFOA and PFOS exposure with liver injury: Evidence from Two Population Studies and integrative adverse outcome pathway analysis.". Environmental pollution (Barking, Essex : 1987). https://doi.org/10.1016/j.envpol.2025.127059 →
  8. db:pubmed Li M, Xu C, Li L et al.. (2025). "Placentation Disruption by Perfluorooctanoic Acid and Perfluorooctanesulfonate in Human Trophoblast Organoids.". Environmental science & technology. https://doi.org/10.1021/acs.est.5c07230 →
  9. db:pubmed de Macedo GT, Claro MT, Ferreira SA et al.. (2025). "Mitochondrial and inflammatory dysfunctions underlie perfluorooctane sulfonic acid (PFOS)-induced neurotoxicity in adult zebrafish.". The Science of the total environment. https://doi.org/10.1016/j.scitotenv.2025.179972 →
  10. db:crossref Yue Zhang, Ni Yan, Jingrui Li et al.. (2024). "The Co-Transport of Perfluorooctane Sulfonic Acid (Pfos) and its Precursor Perfluorooctane Sulfonamide (Pfosa) in Saturated Porous Media". https://doi.org/10.2139/ssrn.4780900 →
  11. db:pubmed Liang P, Tian K, Yang W et al.. (2024). "ACSL4-mediated ZIP7-VDAC3 interaction regulates endoplasmic reticulum-mitochondria iron transfer in hepatocytes under PFOS exposure.". The Science of the total environment. https://doi.org/10.1016/j.scitotenv.2024.177679 →
  12. db:crossref Nicole M. Dennis, Adcharee Karnjanapiboonwong, Seenivasan Subbiah et al.. (2020). "Chronic Reproductive Toxicity of Perfluorooctane Sulfonic Acid and a Simple Mixture of Perfluorooctane Sulfonic Acid and Perfluorohexane Sulfonic Acid to Northern Bobwhite Quail (Colinus virginianus)". Environmental Toxicology and Chemistry. https://doi.org/10.1002/etc.4703 →
  13. db:crossref (0). "TOX-96: 1-Perfluorobutanesulfonic acid (375-73-5), Potassium perfluorohexanesulfonate (3871-99-6), Perfluorooctane sulfonate (1763-23-1), WY-14643 (50892-23-4)". https://doi.org/10.22427/ntp-other-1 →
物质监管状态
清单： EU / REACH Annex XIV. 监管信息——不限制在本店购买。
🧮 化学计量计算器
🧪 化学数据
CAS号
1763-23-1
分子式
C8HF17O3S
摩尔质量
500.13 g/mol
IUPAC名称 (EN)
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid
SMILES
C(C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F
InChIKey
YFSUTJLHUFNCNZ-UHFFFAOYSA-N
📚 Related literature (20 篇文章)

Matched automatically from public bibliographic databases by text similarity. Not curated for this substance, and not part of the safety data sheet.

筛选：
排序：
📈 出版时间线
2022
2023
2024
2025
2026
📡 Data sources

The data in this widget comes from the following verified scientific sources:

  • PubChem — National Center for Biotechnology Information (NCBI/NIH), USA
  • ChEMBL — European Bioinformatics Institute (EMBL-EBI), UK
  • NIST WebBook — National Institute of Standards and Technology, USA

Data is cached locally for speed — the widget also works offline.

🔍 外部标识符
12 / 16个ID系统75%
数据库标识符操作
CAS Registry Number1763-23-1打开 →
PubChem CID74483[1]打开 →
InChIKeyYFSUTJLHUFNCNZ-UHFFFAOYSA-N[1]打开 →
InChIInChI=1S/C8HF17O3S/c9-1(10,3(13,14)5(17,18)7(21,…[1]
SMILESC(C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F)(C(C(C(…[1]
EC Number217-179-8[2]打开 →
ChEMBLCHEMBL1876554[3]打开 →
KEGG CompoundC18142打开 →
HMDBHMDB0059586打开 →
ChemSpider67068[4]打开 →
UNII (FDA)9H2MAI21CL打开 →
WikiData QIDQ902094打开 →

来源：PubChem (NIH)、Wikidata SPARQL、KEGG、ChEMBL (EBI)、CompTox CTX (EPA)。

📚 科学参考文献（芝加哥作者-日期格式） (4 来源)
  1. PubChem. National Center for Biotechnology Information (NIH/NLM), chemical compound database. ↗ applies to: PubChem CID · InChIKey · InChI · SMILES
  2. ECHA. EC Inventory — EINECS, ELINCS, NLP and List Numbers assigned under REACH. Helsinki: European Chemicals Agency. ↗ applies to: EC Number
  3. ChEMBL. European Bioinformatics Institute (EMBL-EBI), bioactivity database. ↗ applies to: ChEMBL
  4. ChemSpider. Royal Society of Chemistry, chemical structure database. ↗ applies to: ChemSpider

Further reading

Publications thematically related to this CAS. They are not the source of any value shown on this card.

扩展参考文献 (5)

  1. ★★☆☆☆ CROSSREF 🔓 开放 ❓ 未验证 Anonymous. "Photodegradation of Perfluorooctanesulfonic Acid on Fe-Zeolites in Water.". https://doi.org/10.1021/acs.est.0c04558.s001. 链接 [访问日期: 2026-10-11] CC0 (metadata)
  2. ★★☆☆☆ CROSSREF 🔓 开放 ❓ 未验证 Anonymous. "Pathways for the Mineralization of Perfluorooctanesulfonic Acid under a Smoldering Reductive Atmosphere.". https://doi.org/10.1021/acs.est.5c12435.s001. 链接 [访问日期: 2026-10-11] CC0 (metadata)
  3. ★★☆☆☆ CROSSREF 🔓 开放 ❓ 未验证 Anonymous. "Perfluorooctanesulfonic Acid and Perfluorooctanoic Acid Promote Migration of Three-Dimensional Colorectal Cancer Spheroids.". https://doi.org/10.1021/acs.est.3c04844.s001. 链接 [访问日期: 2026-10-11] CC0 (metadata)
  4. ★★☆☆☆ CROSSREF 🔓 开放 ❓ 未验证 Anonymous. "Investigation of Perfluorooctanesulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Isomer Profiles in Naturally Contaminated Food Samples.". https://doi.org/10.1021/acs.jafc.5c03790.s001. 链接 [访问日期: 2026-10-11] CC0 (metadata)
  5. ★★☆☆☆ CROSSREF 🔓 开放 ❓ 未验证 Anonymous. "Thermal Decomposition of Perfluorooctanesulfonic Acid (PFOS) in the Presence of Water Vapor.". https://doi.org/10.1021/acs.iecr.2c02463.s001. 链接 [访问日期: 2026-10-11] CC0 (metadata)
📡 光谱学 — CAS 1763-23-1
📊 光谱数据库 — 内联数据 9 来源

光谱按需从9个来源获取。每个光谱都存储在我们的数据库中 — 下次打开时无需向外部API发出请求。无需搜索即可为每个光谱下载JCAMP-DX / CSV / PNG。

IR IR (Infrared) — NIST WebBook
Public domain (US Federal)
▶ 点击加载光谱
🔗 来源
— 点
📚 NIST Chemistry WebBook, SRD 69
MS (NIST) Mass Spectrum (EI) — NIST WebBook
Public domain (US Federal)
▶ 点击加载光谱
🔗 来源
— 点
📚 NIST Standard Reference Database 1A
UV-Vis UV/Visible Absorption — NIST WebBook
Public domain (US Federal)
▶ 点击加载光谱
🔗 来源
— 点
📚 NIST Chemistry WebBook, SRD 69
¹H NMR NMR (¹H, ¹³C) — NMRShiftDB
nmrshiftdb2 Database License
https://nmrshiftdb.nmr.uni-koeln.de/nmrshiftdbhtml/nmrshiftdb2datalicense.txt
Type of data: Predicted (calculated by nmrshiftdb2, not measured) — inferred: the source file carries no deposited measurement
Basis: the file returned by the NMRShiftDB search-or-predict service is a JCAMP-DX LINK block with spectrometer frequency 0, and its values match no deposited NMRShiftDB spectrum of this compound on record at MolGod.
▶ 点击加载光谱
🔗 来源
About the downloads (Type of data: Predicted (calculated by nmrshiftdb2, not measured) — inferred: the source file carries no deposited measurement)
JCAMP: the NMRShiftDB file as received (JCAMP-DX 5.01 text). It is a peak list: chemical shift in ppm. MolGod adds header lines stating the type of data; the values are unchanged.
CSV: the same peak list in two columns. The second column repeats the shift value; it is not a signal intensity. Lines starting with # state the type of data.
PNG: a picture of the plot above, with the type of data written on it.
Use: where signals are expected or were reported (chemical shift positions). Not included or guaranteed: intensities, multiplicities, coupling constants, line shapes, and solvent or temperature unless stated. A predicted list is not a measurement and cannot serve as a reference spectrum for identity or purity testing. Downloads become active after Show.
— 点
📚 Steinbeck C et al. (2003) J. Chem. Inf. Comput. Sci. 43(1):10–16 DOI: 10.1021/ci025588g
MS (MoNA) MoNA — MassBank of North America
CC-BY 4.0
▶ 点击加载光谱
🔗 来源
— 点
📚 MassBank of North America (UC Davis) DOI: 10.1002/jms.1777
IR/NMR/MS (SDBS) SDBS — Spectral Database for Organic Compounds (Japan AIST)
Free for non-commercial

参考来源 — 无公共API。在外部数据库中打开：

🔗 IR/NMR/MS (SDBS) →
📚 SDBSWeb: https://sdbs.db.aist.go.jp (AIST, Japan)
JP Monograph Japanese Pharmacopoeia — Monographs
Reference only

参考来源 — 无公共API。在外部数据库中打开：

🔗 JP Monograph →
📚 Japanese Pharmacopoeia 18th Edition (2021)
WHO INN WHO — International Nonproprietary Names
WHO Model Lists (free)

参考来源 — 无公共API。在外部数据库中打开：

🔗 WHO INN →
📚 WHO INN Programme
DOAJ DOAJ — Directory of Open Access Journals
OA journal index (mixed)

参考来源 — 无公共API。在外部数据库中打开：

🔗 DOAJ →
📚 DOAJ — doaj.org

数据仅获取一次（JCAMP-DX 解析器），并保存在插件的本地数据库中。不重复下载，再次打开时不查询 NIST。遵守许可（仅发布深层链接和自有可视化）。

🔬 交互式光谱（实时 — NIST / MoNA / NMRShiftDB / SDBS） (2)

数据从多个来源实时获取（优先级链）。每个光谱下可下载JCAMP-DX / CSV / PNG。

IR — 傅里叶变换红外光谱

正在加载 IR — 傅里叶变换红外光谱…

MS — 质谱（EI 70eV）

正在加载 MS — 质谱（EI 70eV）…

结构性质

正在加载结构数据...

❓ 常见问题 (3)
What is Perfluorooctanesulfonic acid?
Perfluorooctanesulfonic acid (CAS 1763-23-1) is a chemical compound with the molecular formula C8HF17O3S and a molecular weight of 500.13 g/mol.
有帮助吗？
What is the CAS number of Perfluorooctanesulfonic acid?
The CAS number for Perfluorooctanesulfonic acid is 1763-23-1.
有帮助吗？
What is the chemical formula of Perfluorooctanesulfonic acid?
The molecular formula of Perfluorooctanesulfonic acid is C8HF17O3S.
有帮助吗？
➕ 建议问题
下载结构文件

来自PubChem数据库（NIH）的分子结构文件。兼容Avogadro、PyMOL、Jmol和ChemDraw等程序。

来源：PubChem，美国国家医学图书馆（NIH）。 CID: 74483

🔄 浓度单位转换器 实时

输入Perfluorooctanesulfonic acid浓度（任意单位），其余将自动计算。

分子量： 500.13 g/mol · IUPAC Gold Book ↗

⚗️ 转换公式及引用（每个公式）
转换分子式准确度来源
% (w/v) ↔ molarityc (mol/L) = (% × 10) / MW±0.5% rel. when density ≈ 1.0 g/mLIUPAC (2019)
millimolar ↔ molarc (mol/L) = mM × 10⁻³ExactCohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
molarity (mol/L)c = n/V = (m/MW)/V±0.1% (depends on MW precision)IUPAC (2019)
parts per million (mg/L) ↔ molarityc (mol/L) = ppm / (1000 × MW); equivalently ppm = mg/L for dilute aqueous±1% (density-independent for dilute solutions)IUPAC (2019)
mg/mL ↔ molarityc (mol/L) = (mg/mL × 1000) / MW / 1000 = mg/mL / MW × 1±0.2%Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
g/L ↔ molarityc (mol/L) = (g/L) / MW±0.1% (depends on MW precision)Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
mmol/L ↔ molarityc (mol/L) = mmol/L × 10⁻³ExactCohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
Celsius ↔ KelvinT(K) = t(°C) + 273.15±0.01 K (ITS-90 scale)BIPM (Bureau International des Poids et Mesures) (2019)
Celsius ↔ FahrenheitT(°F) = T(°C) × 9/5 + 32±0.1 °FThompson A, Taylor BN (2008)
density-corrected % ↔ molarityc (mol/L) = (%w/w × ρ × 10) / MW, ρ in g/mL±0.1% when ρ known to 3 decimalsCohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
📚 参考文献（8个权威来源）
  1. Thompson A, Taylor BN (2008). Guide for the Use of the International System of Units (SI). NIST Special Publication 811 · DOI: 10.6028/NIST.SP.811-2008
    → Primary SI standard for US scientific usage
  2. Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007). Quantities, Units and Symbols in Physical Chemistry — The IUPAC Green Book. RSC Publishing, 3rd ed. · DOI: 10.1039/9781847557889 · ISBN: 978-0-85404-433-7
    → Canonical IUPAC guide for chemistry quantities/units
  3. BIPM (Bureau International des Poids et Mesures) (2019). The International System of Units (SI), 9th edition. BIPM · ↗
    → International SI definitions (incl. redefined kilogram 2019)
  4. ISO/IEC (2022). Quantities and units — Part 1: General. International Organization for Standardization — ISO 80000-1:2022 · ↗
    → General rules for physical quantities and units
  5. ISO/IEC (2019). Quantities and units — Part 9: Physical chemistry and molecular physics. International Organization for Standardization — ISO 80000-9:2019 · ↗
    → Concentration / molality / amount-of-substance conventions
  6. Tiesinga E, Mohr PJ, Newell DB, Taylor BN (2021). CODATA recommended values of the fundamental physical constants: 2018. Rev. Mod. Phys. 93(2):025010 · DOI: 10.1103/RevModPhys.93.025010
    → Avogadro, gas constant, molar volume (2019 SI revision)
  7. IUPAC (2019). Compendium of Chemical Terminology — the IUPAC Gold Book (online). IUPAC · DOI: 10.1351/goldbook
    → Definitions of mass fraction, molality, normality, ppm, activity
  8. Mills IM, Cvitaš T, Homann K, Kallay N, Kuchitsu K (1988). Quantities, Units and Symbols in Physical Chemistry. Blackwell Scientific Publications, 1st ed. · ISBN: 0-632-01773-5
    → Historical predecessor of IUPAC Green Book
相似分子结构

正在加载相似结构...

🧪 溶液制备向导 WIZARD
① 选择浓度
② 目标体积
③ 溶剂

计算依据： IUPAC Gold Book ↗, Merck ↗

计算化学

正在加载计算数据...

🛡️ 安全 — CAS 1763-23-1
数据限制说明。 本页安全信息仅供参考，不能替代完整的安全数据表（SDS）。使用产品前，请查阅制造商当前的安全数据表以及GHS/CLP指南。CLP分类适用于纯散装物质，不适用于商业制剂。

GHS/CLP分类——(EC) No 1272/2008法规 + UN GHS Rev. 9 (2021)。

⚠️ 危险 (Danger)
GHS07 — 刺激性/有害
GHS07 刺激性/有害
GHS08 — 健康危害
GHS08 健康危害
GHS09 — 环境危害
GHS09 环境危害

🚨 危险说明（H）

  • H351 — 怀疑会致癌(说明接触途径――如已确证无其他接触途径造成这一危害)
  • H360D — 可能对胎儿造成伤害
  • H362 — 可能对母乳喂养的儿童造成伤害
  • H332 — 吸入有害
  • H302 — 吞咽有害
  • H372 — 长期或反复接触会对器官造成伤害(说明已知的所有受影响器官)( 说明接触途径――如已确证无其他接触途径造成这一危害)
  • H411 — 对水生生物有毒并具有长期持续影响

🛡 防范说明（P）

  • P203 — 使用前取得、阅读并遵循所有安全说明书。

✓ 根据CLP法规(EC) 1272/2008附件VI的统一分类（官方、具有约束力的分类）。 索引号：607-624-00-8。

参考文献（芝加哥格式）： European Chemicals Agency. "perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid, Index No. 607-624-00-8." In Table 3 of Annex VI to Regulation (EC) No 1272/2008 (CLP Regulation), 23rd Adaptation to Technical Progress (harmonised list as of 2026-07-07). Helsinki: European Chemicals Agency, 2026. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp.

翻译：CLP 法规 (EC) 1272/2008，附件 III 和 IV。数据：PubChem/NLM。

📚 综合科学参考文献 — Chicago Author-Date 10 来源

从所有Safety Hub选项卡收集的参考文献。CAS号： 1763-23-1 · PubChem ↗

  1. Parlament Europejski i Rada UE. 2008. "Regulation (EC) nr 1272/2008 w sprawie klasyfikacji, oznakowania i pakowania substancji (CLP)." Dz.Urz. UE L 353. [↗] GHS，法规
  2. United Nations Economic Commission for Europe (UNECE). 2021. "Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Ninth Revised Edition." United Nations, Geneva. [↗] GHS
  3. Goldfrank, Lewis R., Robert S. Hoffman, Mary Ann Howland, et al.. 2019. "Goldfrank's Toxicologic Emergencies, 11th ed.." McGraw-Hill Education, New York. ISBN 978-1-25-985961-8. 急救、毒理学
  4. National Institute for Occupational Safety and Health (NIOSH). 2023. "NIOSH Pocket Guide to Chemical Hazards (DHHS Publ. 2005-149)." U.S. Department of Health and Human Services / CDC, Cincinnati, OH. [↗] 急救、个人防护装备、毒理学
  5. European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms." CEN, Brussels. [↗] 个人防护装备
  6. UNECE. 2023. "European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." United Nations, Geneva. [↗] 处置、法规
  7. National Fire Protection Association (NFPA). 2022. "NFPA 400 — Hazardous Materials Code." NFPA, Quincy, MA. [↗] 储存
  8. Urben, P.G. (ed.). 2017. "Bretherick's Handbook of Reactive Chemical Hazards, 8th ed.." Butterworth-Heinemann / Elsevier, Oxford. [↗] 储存
  9. Ministerstwo Klimatu i Środowiska RP. 2023. "Baza danych o produktach i opakowaniach oraz o gospodarce odpadami (BDO)." Ministerstwo Klimatu i Środowiska, Warszawa. 国家规定——波兰 [↗] 废物处置
  10. International Agency for Research on Cancer (IARC / WHO). 2024. "IARC Monographs on the Identification of Carcinogenic Hazards to Humans — List of Classifications." WHO, Lyon. [↗] 毒理学

具有自身参考文献的选项卡（紧急情况、个人防护装备、储存、废物）在其各自章节中包含额外的书目条目。

📈 分析统计（t检验·RSD·Grubbs·Q-Dixon） ICH Q2

粘贴一系列重复测量结果（CSV或每行一个数字）。计算器将计算平均值、标准差和95%置信区间，并检测异常值（Grubbs + Dixon Q）。

分隔符：逗号、空格、制表符、换行。至少3个测量值。
📐 统计公式
  • x̄ = Σxᵢ / n — 算术平均值
  • s² = Σ(xᵢ - x̄)² / (n-1) — 样本方差
  • s = √s² — 标准差
  • RSD% = (s / x̄) × 100% — 相对标准差
  • CI₉₅ = x̄ ± t(0.05, n-1) × s / √n — Student's t
  • G = |xᵢ - x̄| / s — Grubbs检验
  • Q = |xsuspect - xnearest| / |xmax - xmin| — Dixon Q-test

来源：ICH Q2(R2) 分析方法验证 · ICH PDF ↗

🧪 缓冲液配方计算器 唯一
参考文献： pKa值来自 Goldberg NIST 81 · CRC Handbook 100th ed. · Stoll & Blanchard 1990 (DOI)

从 20 种常用缓冲体系列表中选择 → 输入目标 pH → 获得精确配方，包括称量质量。

步骤 1：选择缓冲体系

📜 配方历史记录（最近 10 条）
药物状态

Prekliniczny

I期
II期
III期
已批准

临床前——无人体研究数据。

ChEMBL CHEMBL1876554 ↗

📅 项目规划器——实验室实验管理器 新品

规划您的整个实验室项目：添加实验（含试剂、重复次数和持续时间）。您将获得甘特图、购物清单（含商店链接！）、预算（含10%余量）和GHS风险矩阵。

🧪 溶解性和溶剂兼容性
分子
Perfluorooctanesulfonic acid
分子式
C8HF17O3S
logP (XLogP3)
5.00
摩尔质量（g/mol）
500.13
极性
疏水性（非极性）

⚠️ GC估算（Hoftyzer-Van Krevelen）。该CAS无文献HSP数据——精度±2 MPa½。请实验验证。

该物质暂无溶剂相容性表。
Hansen 参数超出该方法的范围，因此无法计算距离 Ra，且数据库中也没有可替代的溶解度实测数据。与其给出十一项毫无依据的评级，我们选择不显示。请依据安全数据表和实验数据选择溶剂。
📚 溶剂科学参考文献（芝加哥作者-日期格式）——点击展开

11 种溶剂 · 54 条完整引用（NIST/CRC/IARC/Hansen/Reichardt/Smallwood/Wypych/Armarego/Snyder/GESTIS）— 见下文。

Water (H₂O)
  1. NIST — NIST Chemistry WebBook — Water (CAS 7732-18-5)
  2. CRC — CRC Handbook of Chemistry and Physics, 104th ed., Sec. 8 (Properties of Water)
  3. IAPWS — IAPWS Release on Static Dielectric Constant of Water
  4. Reichardt 2011 — Solvents and Solvent Effects in Organic Chemistry
  5. GESTIS — GESTIS Substance Database — Water
Ethanol (EtOH)
  1. NIST — NIST Chemistry WebBook — Ethanol (CAS 64-17-5)
  2. CRC — CRC Handbook — Ethanol physical constants
  3. Snyder & Kirkland — Modern Liquid Chromatography — Ethanol eluotropic
  4. Smallwood — Handbook of Organic Solvent Properties — Ethanol
  5. GESTIS — GESTIS Substance Database — Ethanol
Methanol (MeOH)
  1. NIST — NIST Chemistry WebBook — Methanol (CAS 67-56-1)
  2. CRC — CRC Handbook — Methanol physical constants
  3. Snyder & Kirkland — Modern Liquid Chromatography — MeOH eluotropic, eo=0.95
  4. GESTIS — GESTIS Substance Database — Methanol
Acetone
  1. NIST — NIST Chemistry WebBook — Acetone (CAS 67-64-1)
  2. CRC — CRC Handbook — Acetone physical & thermodynamic constants
  3. Hansen 2007 — Hansen Solubility Parameters — Acetone (dD=15.5, dP=10.4, dH=7.0)
  4. Smallwood — Handbook of Organic Solvent Properties — Acetone
  5. GESTIS — GESTIS Substance Database — Acetone
Acetonitrile (ACN)
  1. NIST — NIST Chemistry WebBook — Acetonitrile (CAS 75-05-8)
  2. CRC — CRC Handbook — Acetonitrile constants
  3. Snyder & Kirkland — Modern Liquid Chromatography — ACN gold-standard HPLC eluent
  4. Reichardt 2011 — Solvents and Solvent Effects — ACN dipolar aprotic
  5. GESTIS — GESTIS Substance Database — Acetonitrile
DMSO
  1. NIST — NIST Chemistry WebBook — DMSO (CAS 67-68-5)
  2. Wypych 2019 — Handbook of Solvents Vol. 1 — DMSO comprehensive properties
  3. Hansen 2007 — HSP — DMSO (dD=18.4, dP=16.4, dH=10.2)
  4. Reichardt 2011 — Solvents and Solvent Effects — DMSO E_T(30)=45.1, dipolar aprotic
  5. GESTIS — GESTIS Substance Database — DMSO
THF
  1. NIST — NIST Chemistry WebBook — THF (CAS 109-99-9)
  2. Armarego 2009 — Purification of Laboratory Chemicals — THF drying & peroxide test
  3. Hansen 2007 — Hansen Solubility Parameters — THF (dD=16.8, dP=5.7, dH=8.0)
  4. Smallwood — Handbook of Organic Solvent Properties — THF
  5. GESTIS — GESTIS Substance Database — Tetrahydrofuran
DCM (CH₂Cl₂)
  1. NIST — NIST Chemistry WebBook — Dichloromethane (CAS 75-09-2)
  2. IARC 71 — IARC Monograph 71 — DCM (Group 2A carcinogen)
  3. Hansen 2007 — Hansen Solubility Parameters — DCM (dD=18.2, dP=6.3, dH=6.1)
  4. Reichardt 2011 — Solvents and Solvent Effects — DCM polarity index
  5. GESTIS — GESTIS Substance Database — Dichloromethane
Chloroform (CHCl₃)
  1. NIST — NIST Chemistry WebBook — Chloroform (CAS 67-66-3)
  2. IARC 73 — IARC Monograph 73 — Chloroform (Group 2B carcinogen)
  3. Hansen 2007 — Hansen Solubility Parameters — CHCl3 (dD=17.8, dP=3.1, dH=5.7)
  4. Reichardt 2011 — Solvents and Solvent Effects — CHCl3 H-bond donor strength
  5. GESTIS — GESTIS Substance Database — Chloroform
n-Hexane
  1. NIST — NIST Chemistry WebBook — n-Hexane (CAS 110-54-3)
  2. ATSDR n-Hexane — ATSDR Toxicological Profile for n-Hexane — 周围神经病变（正己烷并非 IARC 致癌物）
  3. Hansen 2007 — Hansen Solubility Parameters — n-Hexane (dD=14.9, dP=0, dH=0)
  4. Snyder & Kirkland — Modern Liquid Chromatography — n-Hexane NP standard, eo=0.00
  5. GESTIS — GESTIS Substance Database — n-Hexane
Toluene
  1. NIST — NIST Chemistry WebBook — Toluene (CAS 108-88-3)
  2. IARC 71 — IARC Monograph 71 — Toluene
  3. Hansen 2007 — Hansen Solubility Parameters — Toluene (dD=18.0, dP=1.4, dH=2.0)
  4. Smallwood — Handbook of Organic Solvent Properties — Toluene
  5. GESTIS — GESTIS Substance Database — Toluene
溶解性理论（应用于相容性预测）：
  1. Yalkowsky, Samuel H., and Shri C. Valvani. 1980. "Solubility and Partitioning I: Solubility of Nonelectrolytes in Water." Journal of Pharmaceutical Sciences 69 (8): 912–922. https://doi.org/10.1002/jps.2600690814 — General Solubility Equation (GSE): logS = 0.5 − logP − 0.01(MP−25).
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. CRC Press. https://doi.org/10.1201/9781420006834 — HSP三元组（dD, dP, dH）+ Ra公式。
  3. Stefanis, E., and C. Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." Int J Thermophys 29: 568–585. https://doi.org/10.1007/s10765-008-0415-z
  4. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Wiley-VCH. https://doi.org/10.1002/9783527632220 — E_T(30) polarity scale, solvatochromism.
  5. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley. https://doi.org/10.1002/9780470508183 — Eluotropic series, polarity index.
  6. Van Krevelen, D. W., and K. Te Nijenhuis. 2009. Properties of Polymers. 4th ed. Elsevier. https://doi.org/10.1016/B978-0-08-054819-7.X0001-5 — Hoftyzer–Van Krevelen group contribution for dD/dP/dH from SMILES.
  7. Marcus, Yizhak. 1998. The Properties of Solvents. Wiley Series in Solution Chemistry, Vol. 4. ISBN 9780471983699 — 250+溶剂的完整表格数据集（ε、μ、供体数、受体数）。
  8. PubChem Compound Database — CAS 1763-23-1 lookup ↗ — logP (XLogP3), water solubility experimental + predicted.

完整参考文献位于页面底部的参考文献折叠面板——芝加哥格式手册第17版作者-日期格式。

⚗️ 检查反应兼容性
2 0 0
健康： 2/4
易燃性： 0/4
反应性： 0/4
根据NFPA 704 / 由H代码计算

检查Perfluorooctanesulfonic acid是否与另一种试剂兼容

📦 储存兼容性矩阵
酸类 碱 氧化剂 易燃 毒性 Gazy
酸类 ✓ ✗ ✗ ✗ ⚠ ✗
碱 ✗ ✓ ⚠ ⚠ ⚠ ⚠
氧化剂 ✗ ⚠ ✓ ✗ ⚠ ✗
易燃 ✗ ⚠ ✗ ✓ ⚠ ✗
毒性 ⚠ ⚠ ⚠ ⚠ ✓ ⚠
Gazy ✗ ⚠ ✗ ✗ ⚠ ✓
✓ 可一起储存 · ⚠ 谨慎 · ✗ 禁止一起储存 · OSHA Chemical Segregation ↗

兼容性数据来源： Bretherick's Handbook (7th ed.) ↗, GESTIS ↗, ECHA REACH ↗, NFPA 704 ↗

🧮 实验室计算器（8个）
稀释（C₁V₁=C₂V₂）
摩尔浓度（M=n/V）
pH缓冲液（Henderson-Hasselbalch）
Beer-Lambert（A=εcl）
质量→摩尔
浓度%→M
ppm→mg/L
温度 C↔F↔K

已验证的配方： IUPAC Gold Book ↗, DOI ↗

📊 光谱数据库
📋 实验室方案生成器

方案基于以下内容生成： GHS SDS, Aldrich Lab Guide ↗

🏷️ 标签生成器（QR码）
Perfluorooctane Sulfonic Acid• PFOS / Perfluorooctylsulfonic acid• IUPAC: 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid• CAS: 1763-23-1• EC: 217-179-8• 分子式: C8HF17O3S• 摩尔质量: 500.13 g/mol危险GHS危险说明：H351 H360D H362 H332 H302 H372 H411P203: 使用前取得、阅读并遵循所有安全说明书。仅供实验室使用！Nonsensia Ltd124-128 City Road, EC1V 2NX London[email protected]molgod.org批号: 净含量:
Lipinski 描述符（结构）

类药性雷达图（Lipinski Ro5 / Veber）。绿色区域 = 符合标准。

预测数据 — 通过计算机模拟（SMILES/RDKit）计算的属性。不能替代临床研究。未经实验验证，不得用于药物评估。

MW500.1LogP5HBD1HBA20RotB7TPSA62.8 Ų
✗ Lipinski Ro5 (MW=500, LogP=5, HBA=20)✓ Veber✓ Egan✗ Ghose (MW=500)✗ REOS (MW=500, HBA=20)✗ Lead-like Ro3 (MW=500, LogP=5, HBA=20, RotB=7)
属性值评级
吸收（GI）高✓
血脑屏障通透性否
生物利用度（Daina 2017）
17%
CYP450概况CYP1A2 non-inhibitorCYP2C9 non-inhibitorCYP2C19 non-inhibitorCYP2D6 non-inhibitorCYP3A4 inhibitor
PAINS警告0✓
Brenk警告0✓
pKa (pH 7.4)1 (experimental)
hERG（心脏毒性）✓ 否
P-gp底物—
Ames致突变性✓ 否
DILI（肝毒性）—
LogS（水溶性）—
来源（ADMET方法学）
  1. Lipinski, Christopher A., Franco Lombardo, Beryl W. Dominy, and Paul J. Feeney. 1997. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings." Advanced Drug Delivery Reviews 23 (1-3): 3-25.
  2. Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, et al. 2002. "Molecular properties that influence the oral bioavailability of drug candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
  3. Daina, Antoine, Olivier Michielin, and Vincent Zoete. 2017. "SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness." Scientific Reports 7: 42717.
  4. Egan, William J., and Gregory Lauri. 2002. "Prediction of intestinal permeability." Advanced Drug Delivery Reviews 54 (3): 273-289.
  5. Baell, Jonathan B., and Georgina A. Holloway. 2010. "New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries." Journal of Medicinal Chemistry 53 (7): 2719-2740.
  6. Brenk, Ruth, Alessandro Schipani, Daniel James, et al. 2008. "Lessons learnt from assembling screening libraries for drug discovery for neglected diseases." ChemMedChem 3 (3): 435-444.
  7. Ertl, Peter, and Ansgar Schuffenhauer. 2009. "Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions." Journal of Cheminformatics 1: 8.
  8. Bickerton, G. Richard, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and Andrew L. Hopkins. 2012. "Quantifying the Chemical Beauty of Drugs." Nature Chemistry 4 (2): 90-98.
  9. Hopkins, Andrew L., and Colin R. Groom. 2002. "The Druggable Genome." Nature Reviews Drug Discovery 1 (9): 727-730.
  10. Ghose, Arup K., Vellarkad N. Viswanadhan, and John J. Wendoloski. 1999. "A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery." Journal of Combinatorial Chemistry 1 (1): 55-68.
  11. Tice, Raymond R., Christopher P. Austin, Robert J. Kavlock, and John R. Bucher. 2013. "Improving the Human Hazard Characterization of Chemicals: A Tox21 Update." Environmental Health Perspectives 121 (7): 756-765.
  12. Leeson, Paul D., and Brian Springthorpe. 2007. "The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry." Nature Reviews Drug Discovery 6 (11): 881-890.
  13. Hann, Michael M. 2011. "Molecular Obesity, Potency and Other Addictions in Drug Discovery." MedChemComm 2 (5): 349-355.
  14. Davies, Mark, Michał Nowotka, George Papadatos, et al. 2015. "ChEMBL Web Services: Streamlining Access to Drug Discovery Data and Utilities." Nucleic Acids Research 43 (W1): W612-W620.
  15. Walters, W. Patrick, and Mark A. Murcko. 2002. "Prediction of 'Drug-Likeness.'". Advanced Drug Delivery Reviews 54 (3): 255–271. https://doi.org/10.1016/S0169-409X(02)00003-0.
  16. Congreve, Miles, Robin Carr, Christopher Murray, and Harren Jhoti. 2003. "A 'Rule of Three' for Fragment-Based Lead Discovery?" Drug Discovery Today 8 (19): 876–877. https://doi.org/10.1016/S1359-6446(03)02831-9.
  17. Brenk, Ruth, Alessandro Schipani, Daniel James, Agata Krasowski, Iain Hugh Gilbert, Julie Frearson, and Paul Graham Wyatt. 2008. "Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases." ChemMedChem 3 (3): 435-444.
  18. Schomburg, Karen T., Sascha Bietz, Hans Briem, Andrea M. Henzler, Stefan Urbaczek, and Matthias Rarey. 2014. "Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening." Journal of Chemical Information and Modeling 54 (6): 1676-1686.
  19. Bemis, Guy W., and Mark A. Murcko. 1996. "The Properties of Known Drugs. 1. Molecular Frameworks." Journal of Medicinal Chemistry 39 (15): 2887-2893.
  20. Schomburg, Karen T., and Matthias Rarey. 2014. "What Is the Potential of Structure-Based Target Prediction Methods?" Future Medicinal Chemistry 6 (17): 1987-1989.
  21. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review1
  22. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review2
  23. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review1
  24. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review2
  25. Yu J, Huang S, Zhang J et al.. (2026). "Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis.". Journal of hazardous materials. https://doi.org/10.1016/j.jhazmat.2025.140750
  26. Liu J, Pang X, Li X et al.. (2025). "Perfluorooctanoic acid and perfluorooctanesulfonic acid induce resistance to chemotherapy in colorectal cancer.". Journal of hazardous materials. https://doi.org/10.1016/j.jhazmat.2025.140583
  27. You Y, Guan X, Zhao H et al.. (2025). "Associations of PFOA and PFOS exposure with liver injury: Evidence from Two Population Studies and integrative adverse outcome pathway analysis.". Environmental pollution (Barking, Essex : 1987). https://doi.org/10.1016/j.envpol.2025.127059
  28. Li M, Xu C, Li L et al.. (2025). "Placentation Disruption by Perfluorooctanoic Acid and Perfluorooctanesulfonate in Human Trophoblast Organoids.". Environmental science & technology. https://doi.org/10.1021/acs.est.5c07230
  29. de Macedo GT, Claro MT, Ferreira SA et al.. (2025). "Mitochondrial and inflammatory dysfunctions underlie perfluorooctane sulfonic acid (PFOS)-induced neurotoxicity in adult zebrafish.". The Science of the total environment. https://doi.org/10.1016/j.scitotenv.2025.179972
  30. Yue Zhang, Ni Yan, Jingrui Li et al.. (2024). "The Co-Transport of Perfluorooctane Sulfonic Acid (Pfos) and its Precursor Perfluorooctane Sulfonamide (Pfosa) in Saturated Porous Media". https://doi.org/10.2139/ssrn.4780900
  31. Liang P, Tian K, Yang W et al.. (2024). "ACSL4-mediated ZIP7-VDAC3 interaction regulates endoplasmic reticulum-mitochondria iron transfer in hepatocytes under PFOS exposure.". The Science of the total environment. https://doi.org/10.1016/j.scitotenv.2024.177679
  32. Nicole M. Dennis, Adcharee Karnjanapiboonwong, Seenivasan Subbiah et al.. (2020). "Chronic Reproductive Toxicity of Perfluorooctane Sulfonic Acid and a Simple Mixture of Perfluorooctane Sulfonic Acid and Perfluorohexane Sulfonic Acid to Northern Bobwhite Quail (Colinus virginianus)". Environmental Toxicology and Chemistry. https://doi.org/10.1002/etc.4703
  33. (0). "TOX-96: 1-Perfluorobutanesulfonic acid (375-73-5), Potassium perfluorohexanesulfonate (3871-99-6), Perfluorooctane sulfonate (1763-23-1), WY-14643 (50892-23-4)". https://doi.org/10.22427/ntp-other-1
  34. Anonymous. "Photodegradation of Perfluorooctanesulfonic Acid on Fe-Zeolites in Water.". https://doi.org/10.1021/acs.est.0c04558.s001. [DOI ↗]
  35. Anonymous. "Pathways for the Mineralization of Perfluorooctanesulfonic Acid under a Smoldering Reductive Atmosphere.". https://doi.org/10.1021/acs.est.5c12435.s001. [DOI ↗]
  36. Anonymous. "Perfluorooctanesulfonic Acid and Perfluorooctanoic Acid Promote Migration of Three-Dimensional Colorectal Cancer Spheroids.". https://doi.org/10.1021/acs.est.3c04844.s001. [DOI ↗]
  37. Anonymous. "Investigation of Perfluorooctanesulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Isomer Profiles in Naturally Contaminated Food Samples.". https://doi.org/10.1021/acs.jafc.5c03790.s001. [DOI ↗]
  38. Anonymous. "Thermal Decomposition of Perfluorooctanesulfonic Acid (PFOS) in the Presence of Water Vapor.". https://doi.org/10.1021/acs.iecr.2c02463.s001. [DOI ↗]
  39. Bolton, Evan E., Yanli Wang, Paul A. Thiessen, and Stephen H. Bryant. 2008. "PubChem: Integrated Platform of Small Molecules and Biological Activities." Annual Reports in Computational Chemistry 4: 217-241. [DOI ↗]
  40. Kim, Sunghwan, Jie Chen, Tiejun Cheng, et al. 2023. "PubChem 2023 update." Nucleic Acids Research 51 (D1): D1373-D1380. [DOI ↗]
  41. Kim, Sunghwan, Tiejun Cheng, Jianyong He, Chen Cheng, et al. 2021. "PubChem Protein, Pathway, Reaction, and Disease Specifications." Journal of Cheminformatics 13: 16. [DOI ↗]
  42. Hähnke, Volker D., Sunghwan Kim, and Evan E. Bolton. 2018. "PubChem chemical structure standardization." Journal of Cheminformatics 10: 36. [DOI ↗]
  43. Wang, Yanli, Stephen H. Bryant, Tiejun Cheng, Jiyao Wang, et al. 2017. "PubChem BioAssay: 2017 update." Nucleic Acids Research 45 (D1): D955-D963. [DOI ↗]
  44. Cheng, Tiejun, et al. 2014. "Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge." Journal of Chemical Information and Modeling 54 (3): 793-805. [DOI ↗]
  45. Wilkinson, Mark D., et al. 2016. "The FAIR Guiding Principles for scientific data management and stewardship." Scientific Data 3: 160018. [DOI ↗]
  46. Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, Brian R. Smith, Keith W. Ward, and Kenneth D. Kopple. 2002. "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
  47. ECHA. 2024. "REACH Guidance." European Chemicals Agency. ↗
  48. Groom, Colin R., Ian J. Bruno, Matthew P. Lightfoot, and Suzanna C. Ward. 2016. "The Cambridge Structural Database." Acta Crystallographica Section B 72 (2): 171-179. ↗
🧪 溶液配制助手（Smart Prep）

输入您要制备的内容——我将生成SOP

示例如下——点击插入：
预设配方：
📚 科学文献概览 — CAS 1763-23-1
⭐ 关键发现（科学文献） 17 出版物
🏆 CAS 1763-23-1 — multi-criteria ranking (W12): 30%引用·20%近期性·20%主题·15%历史·15%开放获取.
  1. #1
    Polycarp C. Ofoegbu, Dane C. Wagner, Oluwasegun Michael Abolade et al. (2022) · Journal of Hazardous Materials Advances
    重要性： Open access
    SCORE 10.09 机制 引用： 25 Open Access DOI ↗
  2. #2
    et al. (2025) · Small
    重要性： 近期（2025） · open access
    SCORE 9.76 机制 引用： 7 Open Access DOI ↗ PubMed ↗
  3. #3
    Josiane Weber Tessmann, Pan Deng, Jerika Durham et al. (2024) · Chemosphere
    重要性： 近期（2024） · open access
    SCORE 9.59 机制 引用： 12 Open Access DOI ↗
  4. #4
    et al. (2025) · Chemical Research in Toxicology
    重要性： 近期（2025） · open access
    SCORE 9.15 机制 引用： 4 Open Access DOI ↗ PubMed ↗
  5. #5
    Owen R, de Macedo G, Nerlich J et al. (2025) · Toxicological sciences : an official journal of the Society of Toxicology
    重要性： 近期（2025） · open access
    SCORE 9.11 机制 引用： 8 Open Access DOI ↗ PubMed ↗
  6. #6
    Samuel Thomas, William A. Ricke, Lingjun Li (2023) · Chemical Research in Toxicology
    重要性： 近期（2023） · open access
    SCORE 9.01 机制 引用： 8 Open Access DOI ↗
  7. #7
    et al. (2025) · Journal of Environmental Health Science and Engineering
    重要性： 近期（2025） · open access
    SCORE 8.06 药理学 引用： 3 Open Access DOI ↗ PubMed ↗
  8. #8
    Liu X, Wang X, Wang L (2025) · Ecotoxicology and environmental safety
    重要性： 近期（2025） · open access
    SCORE 7.68 机制 引用： 2 Open Access DOI ↗ PubMed ↗
  9. #9
    et al. (2025) · Toxicological Sciences
    重要性： 近期（2025） · open access
    SCORE 7.15 工业 引用： 1 Open Access DOI ↗ PubMed ↗
  10. #10
    et al. (2025) · Toxicology Reports
    重要性： 近期（2025） · open access
    SCORE 7.15 工业 引用： 1 Open Access DOI ↗ PubMed ↗
  11. #11
    et al. (2026) · Frontiers in Genetics
    重要性： 近期（2026） · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  12. #12
    et al. (2026) · Journal of Cardiovascular Development and Disease
    重要性： 近期（2026） · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  13. #13
    Xianyao Zheng; Jiangbing Qiu; Aifeng Li (2026) · Journal of Hazardous Materials
    重要性： 近期（2026）
    SCORE 6.5 机制 引用： 1 DOI ↗ PubMed ↗
  14. #14
    et al. (2026) · RSC Advances
    重要性： 近期（2026） · open access
    SCORE 6.25 药理学 Open Access DOI ↗ PubMed ↗
  15. #15
    et al. (2025) · ACS Omega
    重要性： 近期（2025） · open access
    SCORE 6.25 机制 Open Access DOI ↗ PubMed ↗
  16. #16
    et al. (2026) · ACS ES&T Air
    重要性： 近期（2026） · open access
    SCORE 6.25 机制 Open Access DOI ↗ PubMed ↗
  17. #17
    Wenlu Li; Fanping Meng (2026) · Bioresource Technology
    重要性： 近期（2026）
    SCORE 4 机制 DOI ↗ PubMed ↗

为什么本页可以核查

标识

CAS、EC 和分子式，已在买方使用的各标识符系统中完成解析。页面显示已解析的系统数量，让您看到该物质的表征程度，而不是凭假设。

数据

每个理化数值都标明其来源及该来源的查阅日期。任何一条都可以打开查看。

分类

如有统一分类条目，则以其为准并注明索引号。自我分类单独列出并加以标注。

法规

名录、限制、授权和候选清单状态均逐一列明。凡状态尚未确定之处，本页会如实说明 — 从不声明不适用任何限制。

文件

有哪些文件、经过何种级别的审核、提供哪些语言，以及每份文件的出具时间。

供应商

谁在销售，以及其公开发布的自身信息。

本页内容均不构成认证。它是一份可供您审核的记录。

Two guarantees, both with their limits stated

The Gap Report Guarantee

If the available evidence cannot support a defensible document for your CAS number and product specification, we will not invent the missing values. You receive a documented gap report and choose: a refund, store credit, or the report on its own.

A visible gap is worth more than a plausible number, because the plausible number is the one that fails when somebody checks it.

The Re-issue Promise

If a signed card is rejected by an authority or by a customer’s compliance officer on one of the points we checked and reported as passed, we re-issue it corrected at no charge and credit the original fee.

This covers the checks we performed and named. It does not cover registration status, tonnage, or your role in the supply chain — those are not ours to hold, and a guarantee that pretended otherwise would be worth nothing.

This page describes the regulatory documentation issued for perfluorooctane sulfonic acid (CAS 1763-23-1). The item supplied is a document, not the substance.

perfluorooctane sulfonic acid (CAS 1763-23-1) at a glance

  • Substance – perfluorooctane sulfonic acid
  • CAS number – 1763-23-1
  • EC number – 217-179-8 [1];220-527-1 [2];274-460-8 [3];249-415-0 [4];249-644-6 [5]
  • CLP Annex VI index number – 607-624-00-8
  • Also known as – heptadecafluorooctane-1-sulfonic acid
  • Hazard statements – H351 (suspected of causing cancer); H360D (may damage the unborn child); H362 (may cause harm to breast-fed children); H332 (harmful if inhaled); H302 (harmful if swallowed); H372 (causes damage to organs through prolonged or repeated exposure)
  • Hazard classes – Carc. 2, Repr. 1B, Lact., Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 1
  • Label pictograms – GHS07, GHS08, GHS09
  • Signal word – Danger
  • Entry current as of – ATP01
  • CMR classification – yes, classified as carcinogenic, mutagenic or toxic for reproduction
  • Documentation issued – safety data sheet in REACH Annex II structure; working draft or signed card
  • What is supplied – a document. MolGod.org does not sell, supply or ship chemical substances.

Aquatic hazard and disposal

Aquatic hazard classification (H411) for CAS 1763-23-1 reaches beyond the label. It governs the environmental section of the safety data sheet, the disposal route stated in section 13, and in several Member States the reporting threshold for storage. Consignments carrying an aquatic hazard also attract marine pollutant marking when moved by sea.

Accidental release and containment

A spill involving substance with CAS number 1763-23-1 must be managed according to Section 6, which should clearly specify the required containment materials and personal protective equipment necessary for personnel approaching the spill site. An operational sheet outlining the cleanup process without detailing the appropriate attire for workers is considered incomplete.

How is perfluorooctane sulfonic acid classified for road, sea and air transport?

The transport classification for perfluorooctane sulfonic acid falls under section 14 and varies depending on the mode of transport: ADR for road, IMDG for sea, and IATA for air. A document that prints all three classifications without specifying which one applies places the responsibility on the shipper to select the correct one, and it is the shipper who faces penalties for making an incorrect choice.

Stability, reactivity and incompatibilities

Incompatibilities for perfluorooctane sulfonic acid should be detailed under section 10 and must not conflict with the storage instructions provided in section 7. If a document lists a material as incompatible in one section while permitting its use in another, it is no longer considered valid.

Identifiers that must agree

The CAS 1763-23-1 number and index number 607-624-00-8 are not interchangeable or decorative elements; they serve distinct purposes. The index number connects to the harmonised classification system, whereas the CAS number links to chemical literature. A document containing one without the other requires readers to independently reconstruct this relationship, which may lead to errors during reconstruction.

What is the EC number for perfluorooctane sulfonic acid?

Alongside CAS 1763-23-1, this substance carries EC number 217-179-8 [1];220-527-1 [2];274-460-8 [3];249-415-0 [4];249-644-6 [5] and Annex VI index 607-624-00-8. European documentation is built around the EC number as often as around the CAS: registration dossiers, the candidate list and customs systems key on it. A safety data sheet quoting only one of the two forces every downstream reader to look up the other.

Which GHS pictograms apply to perfluorooctane sulfonic acid?

The label for perfluorooctane sulfonic acid carries GHS07 (exclamation mark), GHS08 (health hazard), GHS09 (environment), with the signal word Danger. These are not chosen by the supplier: CLP Annex VI states them for CAS 1763-23-1, and the precedence rules in Annex I decide which pictogram is dropped when two would say the same thing. A label showing a different set from the register is wrong even if every hazard statement on it is correct.

What is the CLP classification of perfluorooctane sulfonic acid?

The harmonised classification for CAS 1763-23-1 carries 7 hazard statements: H351, H360D, H362, H332, H302, H372, H411. In plain terms this means suspected of causing cancer; may damage the unborn child; may cause harm to breast-fed children; harmful if inhaled. A harmonised entry is binding across the Union — an importer may not soften it, and a self-classification that diverges from it will not survive an enforcement check.

Can I import perfluorooctane sulfonic acid into the EU?

Placing perfluorooctane sulfonic acid (CAS 1763-23-1) on the European Union market requires a safety data sheet compiled to Annex II of REACH before the first consignment moves. For carboxylic acid esters, customs and carrier checks concentrate on solvent and intermediate shipments, where the classification stated in section 2 must agree with the harmonised entry in CLP Annex VI under index number 607-624-00-8.

Purity, certificates and what the sheet does not say

Purity grade is a certificate question, not a safety data sheet question. The sheet for perfluorooctane sulfonic acid describes the substance; a certificate of analysis describes one batch of it, with the measured result against the specification and the analytical method named per parameter. Laboratories asking for ‘the COA’ usually need both documents.

Is perfluorooctane sulfonic acid classified as a CMR substance?

CAS 1763-23-1 is classified as a CMR substance (H360D). That status changes the obligations attached to every shipment: workplace exposure documentation, restrictions on supply to the general public, and substitution pressure from downstream users who must justify continued use. A safety data sheet for a CMR substance is read more closely than any other, because the classification itself invites scrutiny.

In which language must the SDS for perfluorooctane sulfonic acid be supplied?

Language compliance is mandatory rather than optional. When perfluorooctane sulfonic acid is delivered to a customer, the receiving Member State may mandate the use of its official language, and several do so without exception. An English original that meets an auditor’s requirements in one country can be rejected at the subsequent border, with no alteration to the content but due solely to the choice of language.

What must the label for perfluorooctane sulfonic acid contain?

The supply label for perfluorooctane sulfonic acid is generated from the same classification that drives the safety data sheet: pictograms selected by precedence, one signal word derived from the highest hazard class present, and the hazard statements H351, H360D, H362… reproduced in full. Where the container is too small to carry the complete set at a legible size, there are lawful ways to handle it and unlawful ones that look identical to a non-specialist.

What happens if a consignment of perfluorooctane sulfonic acid is refused?

Refusals related to perfluorooctane sulfonic acid typically arise from three main causes: outdated classification due to amendments, inconsistencies between transport data and shipping documents, and language barriers where the receiving authority does not accept the provided documentation. These issues are not apparent to a reader who perceives the document as professionally presented.

Protective equipment and exposure controls

Laboratories building a risk assessment for perfluorooctane sulfonic acid start from section 8. Where an occupational exposure limit exists it must be stated with its source and averaging period; where none exists, the sheet says so rather than leaving the field blank.

Questions about documentation for perfluorooctane sulfonic acid

What is the CAS number of perfluorooctane sulfonic acid?

CAS 1763-23-1. In CLP Annex VI the same substance carries index number 607-624-00-8, and both identifiers should appear in the documentation.

Is perfluorooctane sulfonic acid a CMR substance?

Yes. The harmonised classification places it among substances classified as carcinogenic, mutagenic or toxic for reproduction, which changes workplace documentation and supply restrictions.

What hazard statements apply to CAS 1763-23-1?

The harmonised entry lists H351, H360D, H362, H332. These are binding across the Union and may not be softened by a self-classification.

In which language must the sheet be supplied?

In an official language of each Member State where perfluorooctane sulfonic acid is placed on the market, unless that State has stated otherwise.

MolGod.org issues documentation and does not sell, supply or ship chemical substances. CAS 1763-23-1 identifies the subject of this document.

您需要哪个版本？

SDS 工作草稿

€49.99

  • 自动交付 付款后，通过电子邮件发送
  • 完整的 REACH 附件 II 16 节结构
  • 对照 ECHA CLP 附件 VI 的分类
  • 附参考文献的公开来源数据
  • 未解决的缺口会被标注，绝不靠猜测填补
  • 用于内部起草和供应商审查。未签署；供应商特定字段可能需要补充。

最适合

  • 在确定之前查看文件将包含的内容
  • 将供应商发给您的文件与登记册比对
  • 找出您现有数据表中的缺漏
  • 在出口决策前准备内部档案
  • 您经手但尚未销售的物质
文件需提供给公司外部时推荐使用

专家审核版 SDS

€249.99

  • 包含工作草稿的全部内容
  • 由合格人员审核 依照附件 II，逐节进行
  • 根据您的公司、产品等级和已确定用途进行调整
  • 已核对目标市场和语言
  • 按您要求的运输方式审核运输部分
  • 五轮修改 按您的要求执行
  • 收到完整资料后 72 小时内。

最适合

  • 任何从贵公司发出的文件
  • 索取该数据表的客户或分销商
  • 随出口货物附带的文件
  • 可能被检查员或主管机构查阅的数据表
  • 替换已被客户拒收的数据表
如不确定，请从上往下阅读左列，停在第一条符合您情况的描述处。
文件用途 工作草稿
€49.99		 专家审核版
€249.99
内部起草与审查 YesYes
核查供应商发给您的数据表 YesYes
发送给您的客户 并非为此编写Yes
随出口货物一同寄运 并非为此编写Yes
供检查员或主管机关审阅 并非为此编写Yes
根据您的公司、等级和已确定用途进行调整 NoYes
由审核人签名并注明日期 NoYes
何时收到 付款后立即收到完整资料后 72 小时内

您可以将草稿发送给任何人。“并非为此编写”的意思正是如此：它没有签名，也没有针对贵公司调整的字段，因此无法回答收件方即将提出的问题。

签名的含义

文件由谁编制
The document is generated by the MolGod engine from ECHA CLP Annex VI and the cited public sources, then read section by section by a qualified scientific reviewer with a degree in chemistry or a related scientific field.
审核范围
我们依照 REACH 附件 II 的结构逐节审阅该数据表。GHS 分类和运输条目将根据文件中引用的来源进行核对，并根据您提供的公司、产品等级和已识别用途对数据表进行调整。
不予核实的内容
我们不检测您的物料，也无法确认您容器中实际装有什么：成分、浓度、杂质或生产路线。这些信息由您提供，并按您提供的内容如实转载。
签名意味着什么 — 以及不意味着什么
The signature records that a qualified scientific reviewer read the document. It is not a government approval, not an ECHA approval, and not a legal certification — no such certification exists for safety data sheets in the EU. A signature does not by itself make a document legally valid or make your business compliant.
您将收到的内容
一份采用 REACH 附件 II 的 16 部分结构的 PDF，已签名并注明日期，附版本信息以及我们无法确定的所有事项清单。包含五轮修改。
交付
在收到您提供的完整资料后 72 小时内。在我们等待答复期间，计时暂停。
退款
审核开始前可全额退款。如证据不足，您可选择退款、商店抵用金或缺漏报告。详见退款政策。

保证不编造数据。 如果现有证据不足以支撑针对该 CAS 号和您的产品规格的可靠文件，我们不会编造缺失数值。您可以选择退款、商店抵用金或一份有据可查的缺漏报告。

将物质或混合物投放市场的供应商仍有责任确保最终的安全数据表与该物料、其已识别用途及其在供应链中的法律角色相符。

不确定哪一种适合？针对您已有的数据表申请免费筛查。

Related products

📋 Status prawny (REACH / TSCA / UK)
JurysdykcjaListaStatusSunset
EUREACH Annex XIVlisted2015-08-17
📄 分析证书（CoA） CAS 1763-23-1 无

数据库中无此产品的证书。

📚 科学参考文献（芝加哥作者-日期格式）——点击展开

批次管理与实验室认证标准——13个独立来源（ICH Q1/Q3/Q6/Q7/Q10 + ISO 17025 + WHO TRS + 21 CFR 211 + EMA + USP + Ph.Eur. + PIC/S + IPEC-PQG）。

  1. International Council for Harmonisation (ICH). 2000. "Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients." ICH Expert Working Group. [链接 ↗] — GMP for APIs — adopted by EMA, FDA, MHLW
  2. International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. [链接 ↗] — Lab accreditation standard underpinning every CoA
  3. World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. [链接 ↗] — WHO TRS No. 957 — global reference for GMP
  4. International Council for Harmonisation (ICH). 2003. "ICH Q1A(R2): Stability Testing of New Drug Substances and Products." International Council for Harmonisation. [链接 ↗] — Source for batch shelf-life and retest dating
  5. International Council for Harmonisation (ICH). 2006. "ICH Q3A(R2): Impurities in New Drug Substances." ICH. [链接 ↗]
  6. International Council for Harmonisation (ICH). 1999. "ICH Q6A: Specifications for New Drug Substances and Products." ICH. [链接 ↗] — CoA acceptance-criteria specification standard
  7. International Council for Harmonisation (ICH). 2008. "ICH Q10: Pharmaceutical Quality System." ICH. [链接 ↗]
  8. U.S. Food and Drug Administration. 2024. "21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals." US Code of Federal Regulations. [链接 ↗] — US legal mandate (Subpart J — Records and Reports)
  9. European Medicines Agency. 2014. "Guideline on Process Validation for Finished Products — Information and Data to Be Provided EMA/CHMP/CVMP/QWP/BWP/70278/2012." European Medicines Agency. [链接 ↗]
  10. United States Pharmacopeial Convention. 2024. "United States Pharmacopeia and National Formulary, USP 47-NF 42." USP. [链接 ↗]
  11. European Pharmacopoeia Commission. 2024. "European Pharmacopoeia 11th Edition." Council of Europe — EDQM. [链接 ↗]
  12. Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. [链接 ↗] — Cross-recognized GMP for 54 inspectorates worldwide
  13. International Pharmaceutical Excipients Council (IPEC) and Pharmaceutical Quality Group (PQG). 2017. "Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients." IPEC-Americas. [链接 ↗] — Excipient-grade CoA standard for non-API ingredients
📜 专利（公开元数据） 无数据

目前未在Crossref/OpenAlex中找到该物质的公开专利元数据。数据将在下次缓存刷新（24小时）后自动更新。

📚 参考文献（芝加哥作者-日期格式）——点击展开
  1. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review1
  2. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v2/review2
  3. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review1
  4. (2026). "Review for "Remediation of Perfluorooctane Sulfonic Acid (PFOS) using Supported Lipid Bilayers on Mesoporous-SiO2"". https://doi.org/10.1039/d6ta01843b/v1/review2
  5. Yu J, Huang S, Zhang J et al.. (2026). "Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis.". Journal of hazardous materials. https://doi.org/10.1016/j.jhazmat.2025.140750
  6. Liu J, Pang X, Li X et al.. (2025). "Perfluorooctanoic acid and perfluorooctanesulfonic acid induce resistance to chemotherapy in colorectal cancer.". Journal of hazardous materials. https://doi.org/10.1016/j.jhazmat.2025.140583
  7. You Y, Guan X, Zhao H et al.. (2025). "Associations of PFOA and PFOS exposure with liver injury: Evidence from Two Population Studies and integrative adverse outcome pathway analysis.". Environmental pollution (Barking, Essex : 1987). https://doi.org/10.1016/j.envpol.2025.127059
  8. Li M, Xu C, Li L et al.. (2025). "Placentation Disruption by Perfluorooctanoic Acid and Perfluorooctanesulfonate in Human Trophoblast Organoids.". Environmental science & technology. https://doi.org/10.1021/acs.est.5c07230
  9. de Macedo GT, Claro MT, Ferreira SA et al.. (2025). "Mitochondrial and inflammatory dysfunctions underlie perfluorooctane sulfonic acid (PFOS)-induced neurotoxicity in adult zebrafish.". The Science of the total environment. https://doi.org/10.1016/j.scitotenv.2025.179972
  10. Yue Zhang, Ni Yan, Jingrui Li et al.. (2024). "The Co-Transport of Perfluorooctane Sulfonic Acid (Pfos) and its Precursor Perfluorooctane Sulfonamide (Pfosa) in Saturated Porous Media". https://doi.org/10.2139/ssrn.4780900
  11. Liang P, Tian K, Yang W et al.. (2024). "ACSL4-mediated ZIP7-VDAC3 interaction regulates endoplasmic reticulum-mitochondria iron transfer in hepatocytes under PFOS exposure.". The Science of the total environment. https://doi.org/10.1016/j.scitotenv.2024.177679
  12. Nicole M. Dennis, Adcharee Karnjanapiboonwong, Seenivasan Subbiah et al.. (2020). "Chronic Reproductive Toxicity of Perfluorooctane Sulfonic Acid and a Simple Mixture of Perfluorooctane Sulfonic Acid and Perfluorohexane Sulfonic Acid to Northern Bobwhite Quail (Colinus virginianus)". Environmental Toxicology and Chemistry. https://doi.org/10.1002/etc.4703
  13. (0). "TOX-96: 1-Perfluorobutanesulfonic acid (375-73-5), Potassium perfluorohexanesulfonate (3871-99-6), Perfluorooctane sulfonate (1763-23-1), WY-14643 (50892-23-4)". https://doi.org/10.22427/ntp-other-1
  14. World Intellectual Property Organization. 2024. "Patent Cooperation Treaty (PCT)." https://www.wipo.int/pct/.
  15. U.S. Patent and Trademark Office. 2024. "USPTO Patent Public Search." https://ppubs.uspto.gov/.
  16. European Patent Office. 2024. "Espacenet Patent Search." https://worldwide.espacenet.com/.
  17. Newman, David J., and Gordon M. Cragg. 2020. "Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019." Journal of Natural Products 83 (3): 770-803.
  18. Davies, Mark, Michał Nowotka, George Papadatos, et al. 2015. "ChEMBL Web Services: Streamlining Access to Drug Discovery Data and Utilities." Nucleic Acids Research 43 (W1): W612-W620.
  19. Bickerton, G. Richard, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and Andrew L. Hopkins. 2012. "Quantifying the Chemical Beauty of Drugs." Nature Chemistry 4 (2): 90-98.
  20. Meanwell, Nicholas A. 2011. "Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design." Journal of Medicinal Chemistry 54 (8): 2529-2591.
  21. Ertl, Peter, and Ansgar Schuffenhauer. 2009. "Estimation of Synthetic Accessibility Score of Drug-Like Molecules Based on Molecular Complexity and Fragment Contributions." Journal of Cheminformatics 1: 8.
  22. Hopkins, Andrew L., and Colin R. Groom. 2002. "The Druggable Genome." Nature Reviews Drug Discovery 1 (9): 727-730.
  23. Allison, John R., and Mark A. Lemley. 1998. "Empirical Evidence on the Validity of Litigated Patents." AIPLA Quarterly Journal 26 (3): 185-275.
  24. Patani, George A., and Edmond J. LaVoie. 1996. "Bioisosterism: A Rational Approach in Drug Design." Chemical Reviews 96 (8): 3147-3176.
  25. Lerner, Josh. 1994. "The Importance of Patent Scope: An Empirical Analysis." RAND Journal of Economics 25 (2): 319-333.

REST: /wp-json/molgod/v1/patents/1763-23-1?status=active&limit=10

数据来自PubChem来源： PubChem (NIH) · ChEMBL
📤 将此分子嵌入您的网站

有博客、论坛或科学网站吗？ 将交互式3D分子嵌入到您的网站上——每位读者都能看到它，下方还有指向我们商店的链接，他们可以在那里购买试剂。

🔗 HTML iframe代码 （最简单——随处可用）

复制并粘贴到您网站的HTML编辑器中：

根据您的布局调整 width 和 height。

⚙ WordPress Shortcode （适用于其他使用MOL-GOD的商店）

🌐 直接链接 （用于电子邮件、聊天、LinkedIn、Twitter）

LinkedIn Twitter/X Facebook
QR code CAS 1763-23-1

📱 QR code （用于印刷在传单/标签/目录上）

将其放置在产品目录、瓶标或传单上。客户扫描后，即可在手机上看到3D分子，并附有指向您商店的链接。

⬇ 下载PNG

🖼 Open Graph image （用于社交媒体元标签）

分享链接时，Facebook/LinkedIn/Discord会自动获取图像预览：

Preview
📋 许可证： 嵌入内容保留反向链接至 MolGod （必需——商店是数据来源）。 化学数据来源于 PubChem (CC0 — 公共领域). 嵌入内容免费用于教育、商业和业余用途。
📚 参考文献（综合书目，芝加哥作者-日期格式） 78 条目

以上折叠面板中针对CAS号1763-23-1引用的所有科学来源。格式： 《芝加哥格式手册》第17版，作者-日期系统.

🗄️ 科学数据库

  1. NIST. n.d. NIST Chemistry WebBook: CAS 1763-23-1. Gaithersburg, MD: National Institute of Standards and Technology. https://webbook.nist.gov/cgi/cbook.cgi?ID=1763-23-1.
  2. AIST. n.d. Spectral Database for Organic Compounds (SDBS): CAS 1763-23-1. Tsukuba, Japan: National Institute of Advanced Industrial Science and Technology. https://sdbs.db.aist.go.jp/.
  3. Linstrom, Peter J., and William G. Mallard, eds. n.d. NIST Chemistry WebBook: NIST Standard Reference Database Number 69. Gaithersburg, MD: National Institute of Standards and Technology. https://doi.org/10.18434/T4D303.
  4. PubChem. n.d. PubChem Compound Summary: CAS 1763-23-1. Bethesda, MD: National Center for Biotechnology Information (NCBI), National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/#query=1763-23-1.
  5. ECHA. n.d. C&L Inventory and REACH Registration: CAS 1763-23-1. Helsinki: European Chemicals Agency. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp.

📐 标准/指南

  1. ICH. 2003. "Stability Testing of New Drug Substances and Products: Q1A(R2)." Geneva: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.
  2. National Fire Protection Association (NFPA). 2024. "NFPA 30: Flammable and Combustible Liquids Code." NFPA, Quincy, MA. https://www.nfpa.org/codes-and-standards/all-codes-and-standards/list-of-codes-and-standards/detail?code=30.
  3. Occupational Safety and Health Administration (OSHA). 2023. "29 CFR 1910.106 — Flammable Liquids." U.S. Department of Labor, Federal Register. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.106.
  4. European Chemicals Agency (ECHA). 2024. "Annex VI to Regulation (EC) No 1272/2008 (CLP) — Harmonised Classification and Labelling." ECHA, Helsinki / Official Journal of the European Union. https://echa.europa.eu/regulations/clp/clp-classification.
  5. European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms — Part 1: Terminology and performance requirements for chemical risks." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=205:110:::::FSP_PROJECT,FSP_ORG_ID:38536,6080&cs=1B0DAA8B85DF42E4A2C70E5D71F0BFA32.
  6. European Committee for Standardization (CEN). 2001. "EN 166:2001 — Personal eye-protection — Specifications." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:6541&cs=1F1A4E0A78C4DB6A28DBE2E8C29D89DCF.
  7. European Committee for Standardization (CEN). 2009. "EN 14605:2005+A1:2009 — Protective clothing against liquid chemicals — Performance requirements for clothing with liquid-tight (Type 3) or spray-tight (Type 4) connections." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:21581&cs=1A04A2D3C7CC58E9E6CB58D55F7EBFB7E.
  8. National Institute for Occupational Safety and Health (NIOSH). 2017. "Recommendations for Chemical Protective Clothing: A Companion to the NIOSH Pocket Guide." U.S. Department of Health & Human Services / CDC. https://www.cdc.gov/niosh/ncpc/default.html.
  9. Occupational Safety and Health Administration (OSHA). 2011. "Personal Protective Equipment — General requirements." U.S. Department of Labor — 29 CFR 1910.132. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.132.

📖 书籍

  1. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook, 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/Hansen-Solubility-Parameters-A-Users-Handbook/Hansen/p/book/9780849372483.
  2. Barton, Allan F. M. 1991. CRC Handbook of Solubility Parameters and Other Cohesion Parameters: 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/CRC-Handbook-of-Solubility-Parameters-and-Other-Cohesion-Parameters/Barton/p/book/9780849301766.
  3. Connors, Kenneth A., Gordon L. Amidon, and Valentino J. Stella. 1986. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd ed.. New York: Wiley. https://doi.org/10.1002/0471734683.
  4. Rumble, John R., ed. 2019. CRC Handbook of Chemistry and Physics: 100th Edition. Boca Raton, FL: CRC Press. https://hbcp.chemnetbase.com/.
  5. Urben, Peter G. 2017. Bretherick's Handbook of Reactive Chemical Hazards, 8th Edition. Academic Press / Elsevier, Oxford. https://www.sciencedirect.com/book/9780081010594.

📄 科学文章（同行评审）

  1. Stefanis, Emmanuel, and Costas Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." International Journal of Thermophysics 29: 568-585. https://doi.org/10.1007/s10765-008-0415-z.
  2. Stoll, Vincent S., and John S. Blanchard. 1990. "Buffers: Principles and Practice: In Methods in Enzymology, vol. 182." San Diego: Academic Press. https://doi.org/10.1016/0076-6879(90)82008-P.

🌐 网站

  1. ECHA. 2023. "Guidance on the Application of the CLP Criteria." European Chemicals Agency. https://echa.europa.eu/guidance-documents/guidance-on-clp.
  2. European Parliament. 2006. "Regulation (EC) No 1907/2006 (REACH)." Official Journal of the European Union L 396: 1–849.
  3. ECHA. 2023. "Candidate List of Substances of Very High Concern for Authorisation." European Chemicals Agency. https://echa.europa.eu/candidate-list-table.
  4. European Parliament. 2008. "Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures (CLP)." Official Journal of the European Union L 353: 1–1355.
  5. ECHA. 2017. "Guidance on the Compilation of Safety Data Sheets." Version 3.1. European Chemicals Agency. ECHA-17-G-01-EN. https://echa.europa.eu/documents/10162/23047722/sds_en.pdf.
  6. ECHA. 2022. "Restrictions Under REACH — Annex XVII." European Chemicals Agency. https://echa.europa.eu/substances-restricted-under-reach.
  7. United Nations. 2021. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 9th revised ed. ST/SG/AC.10/30/Rev.9. New York and Geneva: United Nations. https://unece.org/ghs-rev9-2021.
  8. ECHA. 2020. "Understanding REACH." European Chemicals Agency. https://echa.europa.eu/regulations/reach/understanding-reach.
  9. United States Pharmacopeial Convention. 2024. "USP <621> Chromatography." In United States Pharmacopeia and National Formulary, USP 47-NF 42. Rockville, MD: USP. https://www.uspnf.com/.
  10. European Pharmacopoeia Commission. 2024. "2.2.46 Chromatographic Separation Techniques." In European Pharmacopoeia, 11th ed. Strasbourg: Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
  11. International Council for Harmonisation (ICH). 2022. "ICH Q2(R2): Validation of Analytical Procedures." International Council for Harmonisation. https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2022_1130.pdf.
  12. International Council for Harmonisation (ICH). 1996. "ICH Q3A: Impurities in New Drug Substances." International Council for Harmonisation. https://database.ich.org/sites/default/files/Q3A%28R2%29%20Guideline.pdf.
  13. International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories." Geneva: ISO. https://www.iso.org/standard/66912.html.
  14. Kolthoff, Izaak Maurits, and Philip J. Elving, eds. 1978. Treatise on Analytical Chemistry, Part I: Theory and Practice. 2nd ed. New York: Wiley-Interscience.
  15. Skoog, Douglas A., F. James Holler, and Stanley R. Crouch. 2018. Principles of Instrumental Analysis. 7th ed. Boston: Cengage Learning.
  16. Christian, Gary D., Purnendu K. Dasgupta, and Kevin A. Schug. 2014. Analytical Chemistry. 7th ed. Hoboken, NJ: Wiley.
  17. EURACHEM/CITAC. 2012. "Quantifying Uncertainty in Analytical Measurement." 3rd ed. EURACHEM/CITAC Guide CG 4. https://www.eurachem.org/images/stories/Guides/pdf/QUAM2012_P1.pdf.
  18. International Organization for Standardization. 1994. "ISO 5725-2:1994 Accuracy (Trueness and Precision) of Measurement Methods and Results — Part 2: Basic Method for the Determination of Repeatability and Reproducibility of a Standard Measurement Method." Geneva: ISO. https://www.iso.org/standard/11834.html.
  19. Heckert, N. A., and J. J. Filliben. 2003. "NIST/SEMATECH e-Handbook of Statistical Methods." NIST Handbook 151. Gaithersburg, MD: National Institute of Standards and Technology. https://www.itl.nist.gov/div898/handbook/.
  20. Grubbs, Frank E. 1950. "Sample Criteria for Testing Outlying Observations." Annals of Mathematical Statistics 21 (1): 27–58.
  21. Dixon, Wilfrid J. 1950. "Analysis of Extreme Values." Annals of Mathematical Statistics 21 (4): 488–506.
  22. Snedecor, George W., and William G. Cochran. 1989. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press.
  23. Student [William Sealy Gosset]. 1908. "The Probable Error of a Mean." Biometrika 6 (1): 1–25.
  24. International Organization for Standardization. 2005. "ISO 3534-1:2006 Statistics — Vocabulary and Symbols — Part 1: General Statistical Terms and Terms Used in Probability." Geneva: ISO. https://www.iso.org/standard/40145.html.
  25. Thompson, Michael, Stephen L. R. Ellison, and Roger Wood. 2002. "Harmonized Guidelines for Single-Laboratory Validation of Methods of Analysis." Pure and Applied Chemistry 74 (5): 835–855.
  26. United Nations Economic Commission for Europe. 2024. European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR), Applicable as from 1 January 2025 (ECE/TRANS/352). Geneva: UNECE. https://unece.org/transport/dangerous-goods/adr-2025-edition.
  27. International Air Transport Association. 2026. Dangerous Goods Regulations (DGR). 67th ed. Montreal: IATA. https://www.iata.org/en/programs/cargo/dgr/.
  28. International Maritime Organization. 2024. International Maritime Dangerous Goods (IMDG) Code, 2024 Edition (Amendment 42-24). London: IMO. https://www.imo.org/en/OurWork/Safety/Pages/DangerousGoods-default.aspx.
  29. United Nations. 2025. Recommendations on the Transport of Dangerous Goods: Model Regulations (Orange Book). 24th revised ed. ST/SG/AC.10/1/Rev.24. New York and Geneva: United Nations. https://unece.org/transport/dangerous-goods/un-model-regulations.
  30. International Civil Aviation Organization. 2025. Technical Instructions for the Safe Transport of Dangerous Goods by Air (Doc 9284). 2025–2026 ed. Montreal: ICAO. https://www.icao.int/safety/DangerousGoods/Pages/technical-instructions.aspx.
  31. European Commission. 2014. "Commission Decision 2014/955/EU on the list of waste pursuant to Directive 2008/98/EC." Official Journal of the European Union. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32014D0955.
  32. Ministerstwo Klimatu i Środowiska Rzeczypospolitej Polskiej. 2020. "Rozporządzenie Ministra Klimatu z dnia 2 stycznia 2020 r. w sprawie katalogu odpadów." Dziennik Ustaw RP 2020 poz. 10. https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20200000010. 国家规定——波兰
  33. Główny Inspektorat Ochrony Środowiska (GIOŚ). 2024. "Baza Danych O Odpadach (BDO) — System rejestracji firm utylizacyjnych." Ministerstwo Klimatu i Środowiska. https://bdo.mos.gov.pl/. 国家规定——波兰
  34. Polska — Sejm RP. 2012. "Ustawa z dnia 14 grudnia 2012 r. o odpadach." Dz.U. 2013 poz. 21 (z późn. zm.). https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20130000021. 国家规定——波兰
  35. Furr, A. Keith, ed.. 2000. "CRC Handbook of Laboratory Safety." CRC Press.
  36. Pohanish, Richard P.. 2017. "Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens." Elsevier.
  37. Lewis, Richard J.. 2012. "Sax's Dangerous Properties of Industrial Materials." Wiley.
  38. NIOSH. 2024. "Pocket Guide to Chemical Hazards." U.S. Department of Health and Human Services. https://www.cdc.gov/niosh/npg/.
  39. OSHA. 2024. "Occupational Chemical Database — Hazardous Waste Operations (HAZWOPER)." Occupational Safety and Health Administration. https://www.osha.gov/chemicaldata.
  40. European Parliament and Council. 2008. "Directive 2008/98/EC on waste (Waste Framework Directive)." Official Journal of the European Union L 312/3. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32008L0098.
  41. European Parliament and Council. 2009. "Regulation (EC) No 1272/2008 (CLP) on classification, labelling and packaging of substances and mixtures." Official Journal of the European Union L 353. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32008R1272.
  42. United Nations Economic Commission for Europe (UNECE). 2023. "European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." UNECE. https://unece.org/transport/standards/transport/dangerous-goods/adr-2025.
  43. IPCS INCHEM. 2024. "International Programme on Chemical Safety — Waste Management Guidelines." WHO/UNEP/ILO. https://www.inchem.org/.
  44. European Parliament and Council. 2006. "Regulation (EC) No 1013/2006 on Shipments of Waste." Official Journal of the European Union L 190: 1–98. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32006R1013.
  45. International Council for Harmonisation (ICH). 2000. "Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients." ICH Expert Working Group. https://database.ich.org/sites/default/files/Q7%20Guideline.pdf.
  46. International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. https://www.iso.org/standard/66912.html.
  47. World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. https://www.who.int/publications/m/item/trs957-annex3.
  48. International Council for Harmonisation (ICH). 2003. "ICH Q1A(R2): Stability Testing of New Drug Substances and Products." International Council for Harmonisation. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.
  49. International Council for Harmonisation (ICH). 2006. "ICH Q3A(R2): Impurities in New Drug Substances." ICH. https://database.ich.org/sites/default/files/Q3A%28R2%29%20Guideline.pdf.
  50. International Council for Harmonisation (ICH). 1999. "ICH Q6A: Specifications for New Drug Substances and Products." ICH. https://database.ich.org/sites/default/files/Q6A%20Guideline.pdf.
  51. International Council for Harmonisation (ICH). 2008. "ICH Q10: Pharmaceutical Quality System." ICH. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf.
  52. U.S. Food and Drug Administration. 2024. "21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals." US Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211.
  53. European Medicines Agency. 2014. "Guideline on Process Validation for Finished Products — Information and Data to Be Provided EMA/CHMP/CVMP/QWP/BWP/70278/2012." European Medicines Agency. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions-revision-1_en.pdf.
  54. United States Pharmacopeial Convention. 2024. "United States Pharmacopeia and National Formulary, USP 47-NF 42." USP. https://www.uspnf.com/.
  55. European Pharmacopoeia Commission. 2024. "European Pharmacopoeia 11th Edition." Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
  56. Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. https://picscheme.org/en/publications.
  57. International Pharmaceutical Excipients Council (IPEC) and Pharmaceutical Quality Group (PQG). 2017. "Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients." IPEC-Americas. https://ipecamericas.org/sites/default/files/IPECPQGGMPGuide2017.pdf.
📥 下载BibTeX📥 下载RIS导入到Zotero/Mendeley/EndNote/Papers。
This 3D model is also published on: Wikimedia Commons
Source structure: PubChem (CID 74483)
📜 许可与来源
COMPUTED — PubChem3D · 3D conformer computed by PubChem using OMEGA; not an experimental structure.
Perfluorooctanesulfonic acid (CAS 1763-23-1), C8HF17O3S - 3D ball-and-stick molecular model, engraved element symbols (C H F O S), MolGod STL preview下载图片

MG_886-906-455-45 · engraved · 396,032 △ · 19 MB · SHA-256 8ba3a5983fe659f5

下载 3D 模型 · ENGRAVED · C H F O S

Perfluorooctanesulfonic acid (CAS 1763-23-1), C8HF17O3S - 3D ball-and-stick molecular model, MolGod STL preview下载图片

MG_886-906-455-45 · normal · 12,384 △ · 605 KB · SHA-256 674ec4e634060849

下载 3D 模型

模型
Perfluorooctanesulfonic acid · 1763-23-1
InChIKey
YFSUTJLHUFNCNZ-UHFFFAOYSA-N
许可协议
CC BY-SA 4.0 International
署名
MolGod Scientific — Perfluorooctanesulfonic acid (CAS 1763-23-1)
许可与来源记录
Perfluorooctanesulfonic acid (CAS 1763-23-1) →
MolGod 分子记录
Perfluorooctanesulfonic acid →
源数据
PubChem CID 74483 ↗
模型信息
由 MolGod 生成的 STL · MolGod STL Exporter build 97d4498f28a7 · 生成于 2026-10-04
SHA-256 (STL)
674ec4e634060849079838f0f0a7ed14327d233bb3b4221536a6ebca39330aa6
MD5 (STL)
f1e919cb7e51ec09623dad4f1d67f4f0
MolGod Identification Number
MG_886-906-455-45
转换
MolGod Scientific 球棍模型网格
更改
转换为三角化分子网格；原子坐标与连接关系未改变。
Wikimedia Commons
STL · PNG

本许可适用于 MolGod 创建的 STL 网格，不自动适用于第三方源材料。